ANDRULIS RESEARCH CORPORATION

Organization

BETHESDA, MD, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Use of bis-platinum complexes as antitumor agents
- Patent number 4,720,504
- Issue date Jan 19, 1988
- Andrulis Research Corporation
- Peter J. Andrulis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Stable soluble 1,2-diaminocyclohexane platinum complexes
- Patent number 4,680,308
- Issue date Jul 14, 1987
- Andrulis Research Corporation
- Paul Schwartz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bis-platinum complexes as antitumor agents
- Patent number 4,565,884
- Issue date Jan 21, 1986
- Andrulis Research Corporation
- Peter J. Andrulis
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
74386499 - ANDRULIS/BPRE+
- Serial number 74386499
- Filing date Apr 30, 1993
- ANDRULIS RESEARCH CORPORATION
- 16 - Paper, cardboard and goods made from these materials, not included in other classes
Information Trademark
74386498 - ANDRULIS/BPRE+
- Serial number 74386498
- Registration number 1820112
- Filing date Apr 30, 1993
- ANDRULIS RESEARCH CORPORATION
- 35 - Advertising
Information Trademark
74386424 - BPRE+
- Serial number 74386424
- Filing date Apr 30, 1993
- ANDRULIS RESEARCH CORPORATION
- 16 - Paper, cardboard and goods made from these materials, not included in other classes
Information Trademark
74386423 - BPRE+
- Serial number 74386423
- Registration number 1909433
- Filing date Apr 30, 1993
- ANDRULIS RESEARCH CORPORATION
- 35 - Advertising

NIH Research Projectlast 12 months

processing...

Count: 13

Research Projects

Information Research Project
SOLUBILIZATION AND SUSTAINED DELIVERY OF ANTITUMOR AGENT
- Application id 3492201
- Award notice date May 11, 1990
Information Research Project
POLYMERICS DELIVERY SYSTEMS FOR ANTI-RETROVIRAL AGENTS
- Application id 3489187
- Award notice date Apr 20, 1990
Information Research Project
NEW TARGET DIRECTED PT-PORPHYRIN ANTICANCER DRUGS
- Application id 3491684
- Award notice date Jul 28, 1987
Information Research Project
PALLADIUM COMPLEXES HAVING IN-VIVO ANTITUMOR ACTIVITY
- Application id 3613435
Information Research Project
STABLE ANTITUMOR PLATINUM COMPLEXES PHASE II
- Application id 3506373
Information Research Project
STABILIZATION OF THE ANTICANCER DRUG DACH-PT--NSC 271674
- Application id 3491370
Information Research Project
OPERATE CANCER RES PROJECT/PROTOCOL ANALYSIS CENTER
- Application id 3624285
Information Research Project
MECHANISM-BASED ELASTASE
- Application id 3501054
Information Research Project
POLYMERIC PLATINUM COMPLEXES AS ANICANCER PRODRUGS
- Application id 3613432
Information Research Project
OPERATE CANCER RES PROJECT/PROTOCOL ANALYSIS CENTER
- Application id 3624281
Information Research Project
PALLADIUM COMPLEXES HAVING IN-VIVO ANTITUMOR ACTIVITY
- Application id 3613434
Information Research Project
STABLE ANTITUMOR PLATINUM COMPLEXES PHASE II
- Application id 3506374
Information Research Project
POLYMERIC PLATINUM COMPLEXES AS ANICANCER PRODRUGS
- Application id 3613433

ANDRULIS RESEARCH CORPORATION

Organization

Patents Grantslast 30 patents

Use of bis-platinum complexes as antitumor agents

Stable soluble 1,2-diaminocyclohexane platinum complexes

Bis-platinum complexes as antitumor agents

Trademarklast 30 trademarks

74386499 - ANDRULIS/BPRE+

74386498 - ANDRULIS/BPRE+

74386424 - BPRE+

74386423 - BPRE+

NIH Research Projectlast 12 months

Research Projects

SOLUBILIZATION AND SUSTAINED DELIVERY OF ANTITUMOR AGENT

POLYMERICS DELIVERY SYSTEMS FOR ANTI-RETROVIRAL AGENTS

NEW TARGET DIRECTED PT-PORPHYRIN ANTICANCER DRUGS

PALLADIUM COMPLEXES HAVING IN-VIVO ANTITUMOR ACTIVITY

STABLE ANTITUMOR PLATINUM COMPLEXES PHASE II

STABILIZATION OF THE ANTICANCER DRUG DACH-PT--NSC 271674

OPERATE CANCER RES PROJECT/PROTOCOL ANALYSIS CENTER

MECHANISM-BASED ELASTASE

POLYMERIC PLATINUM COMPLEXES AS ANICANCER PRODRUGS

OPERATE CANCER RES PROJECT/PROTOCOL ANALYSIS CENTER

PALLADIUM COMPLEXES HAVING IN-VIVO ANTITUMOR ACTIVITY

STABLE ANTITUMOR PLATINUM COMPLEXES PHASE II

POLYMERIC PLATINUM COMPLEXES AS ANICANCER PRODRUGS